Indaptus Therapeutics Stock Forward View - Simple Exponential Smoothing
| INDP Stock | USD 1.80 0.04 2.27% |
Predicting Indaptus Therapeutics' future price is a multi-variable problem that combines fundamental signals, technical structure, and market sentiment. This module focuses specifically on the hype and news dimension of that forecast.
At present, the 14-period RSI for Indaptus Therapeutics stands at 44, indicating moderately negative momentum. For Indaptus Therapeutics, this sub-50 reading points to a soft downward drift rather than an aggressive selloff.Momentum
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter -4.32 | EPS Estimate Current Year -25.44 | EPS Estimate Next Year -6.43 | Wall Street Target Price 10 | EPS Estimate Current Quarter -4.17 |
This section relates Indaptus Therapeutics headline activity to recent price behavior and peer context.
The Simple Exponential Smoothing forecasted value of Indaptus Therapeutics on the next trading day is expected to be 1.80 with a mean absolute deviation of 0.12 and the sum of the absolute errors of 7.32.Indaptus Therapeutics after-hype prediction price | $ 1.8 |
Hype signals are presented as complementary context to forecasting, technicals, analyst estimates, earnings, and momentum.
Use Historical Fundamental Analysis of Indaptus Therapeutics to cross-verify projections for Indaptus Therapeutics. The historical view provides additional context.Indaptus Therapeutics Additional Predictive Modules
Most predictive techniques to examine Indaptus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Indaptus using various technical indicators. When you analyze Indaptus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Simple Exponential Smoothing Price Forecast For the 14th of March 2026
Given 90 days horizon, the Simple Exponential Smoothing forecasted value of Indaptus Therapeutics on the next trading day is expected to be 1.80 with a mean absolute deviation of 0.12 , mean absolute percentage error of 0.03 , and the sum of the absolute errors of 7.32 .Please note that although there have been many attempts to predict Indaptus Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Indaptus Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Stock Forecast Pattern
| Backtest Indaptus Therapeutics | Indaptus Therapeutics Price Prediction | Research Analysis |
Forecasted Value
This next-day forecast for Indaptus Therapeutics uses model performance to estimate practical downside and upside boundaries rather than a single point target alone. Investors should still remember that no empirical framework consistently proves that one family of forecasting models will outperform all other approaches in live markets.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Indaptus Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Indaptus Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 114.5923 |
| Bias | Arithmetic mean of the errors | 0.012 |
| MAD | Mean absolute deviation | 0.1201 |
| MAPE | Mean absolute percentage error | 0.0516 |
| SAE | Sum of the absolute errors | 7.3236 |
The concept of mean reversion suggests that Indaptus Therapeutics' price will eventually return toward its long-run average. High prices may deter value investors, while unusually low prices often attract buyers who anticipate a recovery.
After-Hype Price Density Analysis
The price distribution graph for Indaptus Therapeutics visualizes the statistical uncertainty around our prediction model's output. Investors should interpret the full distribution of Indaptus Therapeutics' outcomes, not just the central tendency, when making decisions.
Next price density |
| Expected price to next headline |
Estimiated After-Hype Price Volatility
The downside and upside margins for Indaptus Therapeutics after major news events are estimated from historical precedent. Indaptus Therapeutics' after-hype downside and upside margins for the prediction period are 0.09 and 9.49, respectively. This approach captures the empirical distribution of Indaptus Therapeutics' short-term price reactions without assuming any particular model of future behavior.
Current Value
The after-hype framework applied to Indaptus Therapeutics assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. This view is most useful when investors want to compare sentiment-driven price extension with a more measured post-news scenario.
Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Indaptus Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Indaptus Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Indaptus Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.14 | 7.72 | 0.02 | 0.01 | 8 Events | 6 Events | In 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.80 | 1.80 | 0.00 |
|
Hype Timeline
Indaptus Therapeutics is currently traded for 1.80. The company has historical hype elasticity of 0.02, and average elasticity to hype of competition of 0.01. Indaptus is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at -0.14%. %. The volatility of related hype on Indaptus Therapeutics is about 17545.45%, with the expected price after the next announcement by competition of 1.81. About 37.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.86. Some equities with similar Price to Book (P/B) outperform the market in the long run. Indaptus Therapeutics recorded a loss per share of 29.03. The company last dividend was issued on the 30th of October 2020. The firm completed a 1:28 stock split on 27th of June 2025. Given the investment horizon of 90 days the next forecasted press release will be in 8 days. Use Historical Fundamental Analysis of Indaptus Therapeutics to cross-verify projections for Indaptus Therapeutics. The historical view provides additional context.Related Hype Analysis
The relationship between Indaptus Therapeutics and its sector peers means that news affecting one company often reverberates across Indaptus Therapeutics' competitive landscape. Tracking peer hype helps investors anticipate Indaptus Therapeutics's likely short-term price behavior.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SLXN | Biomotion Sciences Ordinary | -0.15 | 4 per month | 0.00 | -0.11 | 10.98 | -9.17 | 29.74 | |
| REVB | Revelation Biosciences | 0.09 | 9 per month | 0.00 | -0.29 | 5.56 | -10.16 | 34.09 | |
| PBM | Psyence Biomedical Ltd | 0.30 | 10 per month | 0.00 | -0.22 | 9.96 | -12.68 | 48.52 | |
| NKGN | NKGen Biotech Common | 0.00 | 0 per month | 9.18 | 0.16 | 35.14 | -10.00 | 298.33 | |
| GTBP | GT Biopharma | 0.02 | 9 per month | 0.00 | -0.05 | 8.33 | -10.64 | 37.01 | |
| ATXI | Avenue Therapeutics | 0.19 | 5 per month | 0.00 | -0.02 | 22.22 | -21.43 | 122.38 | |
| PTIX | Protagenic Therapeutics | 0.02 | 4 per month | 0.00 | -0.10 | 19.57 | -18.37 | 58.73 | |
| SLRX | Salarius Pharmaceuticals | -0.02 | 6 per month | 0.00 | -0.18 | 16.00 | -16.92 | 61.05 | |
| LIPO | Lipella Pharmaceuticals Common | 0.00 | 1 per month | 0.00 | -0.01 | 18.75 | -21.74 | 94.73 | |
| AZTR | Azitra Inc | -0.01 | 7 per month | 0.00 | -0.12 | 7.14 | -11.11 | 40.00 |
Other Forecasting Options for Indaptus Therapeutics
Whether a novice or experienced investor, anyone considering Indaptus needs to understand the dynamics of Indaptus Therapeutics' price movement. Price charts for Indaptus Stock contain a significant amount of noise that can distort investment decisions.Indaptus Therapeutics Related Equities
The following equities are related to Indaptus Therapeutics within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Indaptus Therapeutics against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
Indaptus Therapeutics Market Strength Events
Analyzing market strength indicators for Indaptus Therapeutics enables investors to understand how the stock performs relative to overall market momentum. These indicators are valuable tools for identifying when to enter or exit positions in Indaptus Therapeutics.
Indaptus Therapeutics Risk Indicators
Identifying and analyzing Indaptus Therapeutics' key risk indicators is a foundational step in projecting how its price may evolve. This process helps investors quantify the risk associated with Indaptus Therapeutics' and decide how to manage it.
| Mean Deviation | 5.04 | |||
| Standard Deviation | 7.44 | |||
| Variance | 55.4 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Indaptus Therapeutics
Coverage intensity for Indaptus Therapeutics matters because narrative visibility can influence sentiment, participation, and volatility around the name. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Contributor Headline
Latest Perspective From Macroaxis
Indaptus Therapeutics Short Properties
Short sentiment tied to Indaptus Therapeutics matters because heavier bearish pressure can change how quickly future price expectations become unstable. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 9.4 M | |
| Cash And Short Term Investments | 5.8 M |
Additional Tools for Indaptus Stock Analysis
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |